Literature DB >> 571061

Phenytoin hepatotoxicity: a case report and review.

W A Parker, C A Shearer.   

Abstract

A 17-year-old woman with phenytoin-induced hepatotoxicity was compared with 23 other cases from the literature. Hepatic injury caused by phenytoin is rare but important because of its significant morbidity and mortality. A typical multisystem clinical pattern precedes the manifestations of hepatic dysfunction. Pathologic findings indicate a mixed hepatocellular damage of cholestasis and necrosis. Pathogenic mechanisms are unexplained, but a delayed hypersensitivity reaction appears likely.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 571061     DOI: 10.1212/wnl.29.2.175

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  8 in total

1.  The influence of long-term anticonvulsant therapy with diphenylhydantoin and carbamazepine on serum gamma-glutamyltransferase, aspartate aminotransferase, alanine aminotransferase and alkaline phosphatase.

Authors:  H G Aldenhövel
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1988

Review 2.  Anticonvulsant hypersensitivity syndrome: incidence, prevention and management.

Authors:  S R Knowles; L E Shapiro; N H Shear
Journal:  Drug Saf       Date:  1999-12       Impact factor: 5.606

Review 3.  Anticonvulsant drugs. An update.

Authors:  M J Eadie
Journal:  Drugs       Date:  1984-04       Impact factor: 9.546

4.  Clinical pharmacogenetics implementation consortium guidelines for CYP2C9 and HLA-B genotypes and phenytoin dosing.

Authors:  K E Caudle; A E Rettie; M Whirl-Carrillo; L H Smith; S Mintzer; M T M Lee; T E Klein; J T Callaghan
Journal:  Clin Pharmacol Ther       Date:  2014-08-06       Impact factor: 6.875

Review 5.  Drug-induced severe skin reactions. Incidence, management and prevention.

Authors:  P Wolkenstein; J Revuz
Journal:  Drug Saf       Date:  1995-07       Impact factor: 5.606

6.  Bile ductopenia following therapy with sulpiride.

Authors:  D Villari; F Rubino; F Corica; S Spinella; E Di Cesare; G Longo; G Raimondo
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

Review 7.  Allergic emergencies encountered by the dermatologist. Severe cutaneous adverse drug reactions.

Authors:  P Wolkenstein; J Revuz
Journal:  Clin Rev Allergy Immunol       Date:  1999       Impact factor: 10.817

Review 8.  Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing: 2020 Update.

Authors:  Jason H Karnes; Allan E Rettie; Andrew A Somogyi; Rachel Huddart; Alison E Fohner; Christine M Formea; Ming Ta Michael Lee; Adrian Llerena; Michelle Whirl-Carrillo; Teri E Klein; Elizabeth J Phillips; Scott Mintzer; Andrea Gaedigk; Kelly E Caudle; John T Callaghan
Journal:  Clin Pharmacol Ther       Date:  2020-09-06       Impact factor: 6.875

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.